Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 46,543 | 0.1% | 102,663 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 40,234 | 0.1% | 102,732 | 9/30/2025 |
| 2025 Q2 | 7/15/2025 | 47,216 | 0.2% | 106,055 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 52,982 | 0.2% | 109,282 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 46,652 | 0.2% | 115,847 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 56,727 | 0.2% | 121,973 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 57,948 | 0.2% | 123,631 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 54,351 | 0.2% | 130,024 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 56,842 | 0.2% | 139,699 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 47,926 | 0.2% | 137,820 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 51,821 | 0.2% | 147,255 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 48,434 | 0.2% | 153,726 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 45,170 | 0.2% | 156,418 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 45,024 | 0.2% | 155,501 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 43,396 | 0.2% | 154,001 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 39,850 | 0.1% | 152,699 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 34,479 | 0.1% | 157,009 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 29,903 | 0.1% | 164,854 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 33,464 | 0.1% | 165,966 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 36,265 | 0.1% | 168,761 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 36,854 | 0.2% | 155,937 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 39,790 | 0.2% | 146,223 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 41,331 | 0.2% | 142,367 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 34,083 | 0.2% | 143,238 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 34,045 | 0.2% | 155,491 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 5,310 | 0.0% | 75,085 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 6,651 | 0.0% | 89,521 | 12/31/2013 |